Association of human carboxypeptidase e exon5 gene polymorphisms with angiographical characteristics of coronary atherosclerosis in a Chinese population

Acta Pharmacologica Sinica

Volumn 29, Issue 6, 2008, Pages 736-744

  Wang, Jie ^a   Zhang, Yun ^b   Yang, Zhi Jian ^a   Zhu, Tie Bing ^a   Wang, Lian Sheng ^a   Chen, Bo ^a   Cao, Ke Jiang ^a   Huang, Jun ^a   Ma, Wen Zhu ^a   Jia, En Zhi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

Author keywords

Carboxypeptidase E gene; Chinese; Coronary atherosclerosis; Gensini's score; Polymorphism; Proinsulin

Indexed keywords

CARBOXYPEPTIDASE H; GLUCOSE; INSULIN; PROINSULIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; EXON; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HOMOZYGOTE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SEX RATIO; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTHROPOMETRY; ATHEROSCLEROSIS; CARBOXYPEPTIDASE H; CHINA; CORONARY ANGIOGRAPHY; DNA; EXONS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44849087011     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00798.x     Document Type: Article

References (25)

1. Utsunomiya N, Ohagi S, Sanke T, Tatsuta H, Hanabusa T, Nanjo K. Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity. Diabetologia 1998 41:701 5.
2. Chen H, Jawahar S, Qian Y, Duong Q, Chan G, Parker A, et al. Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat 2001 18:120 31.
3. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993 10:313 20.
4. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 1987 30:698 702.
5. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, et al. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995 10:135 42.
6. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davey Smith G. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 2002 45:327 36.
7. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C. Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation 2002 105:2153 8.
8. Zethelius B, Lithell H, Hales CN, Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 2005 48:862 7.
9. Lindahl B, Dinesen B, Eliasson M, Roder M, Jansson JH, Huhtasaari F, et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 1999 48:1197 202.
10. Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B. High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 2000 31:2936 41.
11. Welborn TA, Wearne K. Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979 2:154 60.
12. Ducimetière D, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980 19:205 10.
13. Pyörälä K, Savolainen S, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population. Acta Med Scand Suppl 1985 701:38 52.
14. Båvenholm P, Proudler A, Tornvall P, Godsland I, Landou C, de Faire U, et al. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 1995 92:1422 9.
15. Takezako T, Saku K, Zhang B, Shirai K, Arakawa K. Insulin resistance and angiographical characteristics of coronary atherosclerosis. Jpn Circ J 1999 63:666 73.
16. Judkins MP. A percutaneous transfemoral technique. Radiology 1967 89:815 21.
17. Gensini GG. Coronary arteriography. New York:Mount Kisco Futura Publishing Co 1975. p 271 4.
18. Gensini GG. Coronary arteriography. In:Braunwald E, editor. Heart disease. Philadelphia:WB Saunders 1980. p 352 3.
19. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983 51:606.
20. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993 39:578 82.
21. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993 39:2146 50.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28:412 9.
23. Williams RR. Understanding genetic and environmental risk factors in susceptible persons. West J Med 1984 141:799 806.
24. Fricker LD. Peptide processing exopeptidases: amino and cardoxypeptidases involved with peptide biosynthesis. In:Fricker LD, editor, Peptide biosynthesis and processing. Boca Raton:CRC Press 1991. p 199 228.
25. Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, et al. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe (fat) mice. Cell 1997 88:73 83.